1,513
Views
2
CrossRef citations to date
0
Altmetric
Report

An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD

, , , , &
Pages 24-28 | Received 13 Nov 2019, Accepted 13 Dec 2019, Published online: 27 Dec 2019

References

  • Iwasaki Y. Creutzfeldt-Jakob disease. Neuropathology. 2017;37(2):174–188.
  • Puoti G , Bizzi A , Forloni G , et al. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012;11(7):618–628.
  • Heidenhain A. Klinische und anatomische Untersuchungen über eine eigenartige organische Erkrankung des Zentralnervensystems im Praesenium. Zeitschrift Für Die Gesamte Neurologie Und Psychiatrie. 1929;118(1):49–114.
  • Baiardi S , Capellari S , Ladogana A , et al. Revisiting the Heidenhain variant of Creutzfeldt-Jakob disease: evidence for prion type variability influencing clinical course and laboratory findings. J Alzheimers Dis. 2016;50(2):465–476.
  • Cooper SA , Murray KL , Heath CA , et al. Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the “Heidenhain variant”. Br J Ophthalmol. 2005;89(10):1341–1342.
  • Schmitz M , Cramm M , Llorens F , et al. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc. 2016;11(11):2233–2242.
  • Karch A , Raddatz LM , Ponto C , et al. Diagnostic profiles of patients with late-onset Creutzfeldt-Jakob disease differ from those of younger Creutzfeldt-Jakob patients: a historical cohort study using data from the German National Reference Center. J Neurol. 2014;261(5):877–883.
  • Kropp S , Schulz-Schaeffer WJ , Finkenstaedt M , et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol. 1999;56(1):55–61.
  • Clarencon F , Gutman F , Giannesini C , et al. MRI and FDG PET/CT findings in a case of probable Heidenhain variant Creutzfeldt-Jakob disease. J Neuroradiol. 2008;35(4):240–243.
  • Mathews D , Unwin DH . Quantitative cerebral blood flow imaging in a patient with the Heidenhain variant of Creutzfeldt-Jakob disease. Clin Nucl Med. 2001;26(9):770–773.
  • Jacobs DA , Lesser RL , Mourelatos Z . et al. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuro Ophthalmol. 2001;21(2):99–102.
  • Pachalska M , Kurzbauer H , Forminska-Kapuscik M , et al. Atypical features of dementia in a patient with Creutzfeldt-Jakob disease. Med Sci Monit. 2007;13(1):CS9–19.
  • Rizzo M , Bruni A , Barberio C , et al. A Heidenhain variant of Creutzfeldt-Jakob disease: forensic implication. Forensic Sci Int. 2004;146(Suppl):S51–4.
  • Muayqil T , Gronseth G , Camicioli R . Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012;79(14):1499–1506.
  • Connor A , Wang H , Appleby BS , et al. Clinical laboratory tests used to aid in diagnosis of human prion disease. J Clin Microbiol. 2019 Oct;57(10):e00769-19.
  • Collins SJ , Sanchez-Juan P , Masters CL , et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt–jakob disease. Brain. 2006;129(9):2278–2287.
  • Pichler R , Ciovica I , Rachinger J , et al. Multitracer study in Heidenhain variant of Creutzfeldt-Jakob disease: mismatch pattern of cerebral hypometabolism and perfusion imaging. Neuro Endocrinol Lett. 2008;29(1):67–68.
  • Thomas A , Klein JC , Galldiks N , et al. Multitracer PET imaging in Heidenhain variant of Creutzfeldt-Jakob disease. J Neurol. 2006;253(2):258–260.
  • Matías-Guiu JA , Guerrero-Márquez C , Cabrera-Martín MN , et al. Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: correlation with pathological prion protein in neuropathology. Prion. 2017;11(3):205–213.
  • Renard D , Castelnovo G , Collombier L , et al. FDG-PET in Creutzfeldt-Jakob disease: analysis of clinical-PET correlation. Prion. 2017;11(6):440–453.
  • Atarashi R , Satoh K , Sano K , et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17(2):175–178.
  • Atarashi R , Wilham JM , Christensen L , et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods. 2008;5(3):211–212.
  • Foutz A , Appleby BS , Hamlin C , et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann Neurol. 2017 Jan;81(1):79–92.
  • Franceschini A , Baiardi S , Hughson AG , et al. High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci Rep. 2017 Sep 6;7(1):10655.
  • Bongianni M , Orrù C , Groveman BR , et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol. 2017;74(2):155–162.
  • Sano K , Satoh K , Atarashi R , et al. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PloS One. 2013;8(1):e54915.
  • Cramm M , Schmitz M , Karch A , et al. Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol. 2016;53(3):1896–1904.
  • Prevention CfDCa . CDC’s diagnostic criteria for Creutzfeldt-Jakob Disease (CJD), 2018: centers for disease control and prevention; 2018 [cited 2019 Dec 7 ]. Available from: https://www.cdc.gov/prions/cjd/diagnostic-criteria.html
  • Zerr I , Steinhoff BJ , Kallenberg K , et al. Creutzfeldt-Jakob-Krankheit, S1-Leitlinie, 2018. Deutsche Gesellschaft für Neurologie (Hrsg), Leitlinien für Diagnostik und Therapie in der Neurologie; 2018.